Mariela Blum Murphy

Associate Professor

  • 855 Citations
  • 18 h-Index
20112019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mariela Blum Murphy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Stomach Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Esophagogastric Junction Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

4 Citations (Scopus)
Gastrectomy
Stomach Neoplasms
Neoplasm Metastasis
Drug Therapy
Cell Biology

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response

Wang, R., Song, S., Harada, K., Ghazanfari Amlashi, F., Badgwell, B. D., Pizzi, M. P., Xu, Y., Zhao, W., Dong, X., Jin, J., Wang, Y., Scott, A., Ma, L., Huo, L., Vicente, D., Blum Murphy, M., Shanbhag, N., Tatlonghari, G., Thomas, I., Rogers, J. & 19 others, Kobayashi, M., Vykoukal, J., Estrella, J. S., Roy Chowdhuri, S., Han, G., Zhang, S., Mao, X., Song, X., Zhang, J., Gu, J., Johnson, R. L., Calin, G. A., Peng, G., Lee, J-S., Hanash, S., Futreal, A., Wang, Z., Wang, L. & Ajani, J. A., Jan 1 2019, In : Gut.

Research output: Contribution to journalArticle

Open Access
Stomach
Adenocarcinoma
Neoplasm Metastasis
Carcinoma
Exome

Ramucirumab and Paclitaxel Administered Every 2 Weeks (mRAINBOW Regimen) in Advanced Gastroesophageal Adenocarcinoma

Rogers, J. E., Xiao, L., Amlashi, F. G., Elimova, E., Blum Murphy, M., Sanders, E., Shanbhag, N., Thomas, I. & Ajani, J. A., May 1 2019, In : Oncology (Switzerland). 96, 5, p. 252-258 7 p.

Research output: Contribution to journalArticle

Paclitaxel
Adenocarcinoma
Survival
Safety
Esophagogastric Junction

Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma

Tong, Z., Mejia, A., Veeranki, O., Verma, A., Correa, A. M., Dokey, R., Patel, V., Solis Soto, L. M., Mino, B., Kathkuda, R., Rodriguez Canales, J., Lin, S. H., Krishnan, S., Kopetz, E. S., Blum Murphy, M., Ajani, J. A., Hofstetter, W. L. & Maru, D. M., Jul 1 2019, In : Therapeutic Advances in Medical Oncology. 11

Research output: Contribution to journalArticle

Open Access
Fluorouracil
Adenocarcinoma
Heterografts
Down-Regulation
Neoplasms

Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort

Elimova, E., Wang, X., Qiao, W., Sudo, K., Wadhwa, R., Shiozaki, H., Shimodaira, Y., Planjery, V., Charalampakis, N., Lee, J. H., Weston, B., Bhutani, M., Komaki, R., Rice, D. C., Swisher, S. G., Blum Murphy, M., Rogers, J. E., Skinner, H., Maru, D. M., Hofstetter, W. L. & 1 others, Ajani, J. A., May 1 2018, In : Oncology (Switzerland). 94, 6, p. 345-353 9 p.

Research output: Contribution to journalArticle

Esophageal Neoplasms
Recurrence
Therapeutics
Fine Needle Biopsy
Endoscopy